Has Venrice Kerr received payments from drug or device companies?

Yes. Drug and device makers reported $1,196 in general payments to Venrice Kerr across 51 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Venrice Kerr did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Venrice Kerr come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Venrice Kerr

Psychiatric/Mental Health · Annapolis, MDNPI 1659517753

Payments from drug & device makers

$1,196in general payments, 2019–2025

Across 51 payments — averaging $23.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$234
Vanda Pharmaceuticals Inc.$153
Neurocrine Biosciences, Inc.$144
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$113
Alkermes, Inc.$99
Johnson & Johnson$73
plus $380 from 10 others

What the payments were for

Food & beverage$1,196100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	10	$234
Vanda Pharmaceuticals Inc.	6	$153
Neurocrine Biosciences, Inc.	5	$144
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$113
Alkermes, Inc.	5	$99
Johnson & Johnson	2	$73
Otsuka America Pharmaceutical, Inc.	3	$62
Axsome Therapeutics, Inc.	2	$48
Vertical Pharmaceuticals, LLC	2	$47
Tempus AI, Inc	2	$43
E.r. Squibb & Sons, L.L.C.	2	$40
Lundbeck LLC	2	$38
Tris Pharma Inc	2	$35
Teva Pharmaceuticals USA, Inc.	2	$32
Takeda Pharmaceuticals U.S.A., Inc.	1	$17
Supernus Pharmaceuticals, Inc.	1	$17

How this compares

$1,196 in reported general payments places this provider in the 75th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland →

Medicare billing

Part B allowed, 2024

$17,586

Medicare patients

Services billed

161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mirtazapine	28	$688
Quetiapine Fumarate	15	$408
Escitalopram Oxalate	25	$330
Bupropion XlBupropion Hcl	18	$183
Aripiprazole	11	$168
Trazodone Hcl	23	$157
Prazosin Hcl	12	$135
Sertraline Hcl	13	$132
Paroxetine Hcl	17	$105
Lamotrigine	17	$95
Duloxetine Hcl	16	$94

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Annapolis

Hara OyedejiOwings Mills$780K
Ilya RozenbergGlen Burnie$572K
Michelle WilliamsColumbia$158K
Kristin ClemensGaithersburg$36K
Antonio HeroldHavre de Grace$23K
Paul KlaverweidenFruitland$17K
Margaret WebbAberdeen$16K
Susan KrausTowson$16K
Anyinke AtabongRockville$15K
Zenatsehay GebretsadikColumbia$15K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →